Rwilmer
Well-known member
Tamiflu for the treatment of influenza virus mutated
Saturday, October 3rd, 2009 - 14:00
World Health Organization
Abdul Salam wrote Princess
WHO has identified two cases in which high risk of viruses resistant to "oseltamivir" the scientific name for Tamiflu, the processor of the mutated variants of avian and swine influenza, the first case for those suffering from a weakened immune system and their long illness, and received treatment with oseltamivir for a long time, but still seems show signs of virus replication, they have.
The second case to the people who receive oseltamivir in the framework of the so-called "post-exposure prophylaxis" after being exposed to another person with the flu, and those who get sick after that despite receiving the drug.
It is recommended that health professionals, in both cases the response to show a high level of suspicion that resistance to Alooseltamvir may have already emerged. And laboratory investigations must be done in order to identify whether there is a virus-resistant, and whether it should implement infection control measures or strengthened to prevent the spread of the virus.
Also recommended that the Organization should seek, when it is detected by a virus-resistant, to conduct epidemiological investigations to determine whether there is continuity in the transmission. Should also be sought, at the community level, to strengthen surveillance of pandemic strains of H1N1 resistance to Oositamifir.
And called for the need for early treatment with antiviral medicines for those infected with swine flu, and headed "oseltamivir" or "zanamivir" This comes in light of the growing treatment of infections caused by the H1N1 pandemic virus particularly vulnerable patients, more than others, at risk for complications, or who appear their symptoms is high, or in acute signs and symptoms of the disease
http://www.youm7.com/News.asp?NewsID=141773&SecID=97&IssueID=0
Saturday, October 3rd, 2009 - 14:00
World Health Organization
Abdul Salam wrote Princess
WHO has identified two cases in which high risk of viruses resistant to "oseltamivir" the scientific name for Tamiflu, the processor of the mutated variants of avian and swine influenza, the first case for those suffering from a weakened immune system and their long illness, and received treatment with oseltamivir for a long time, but still seems show signs of virus replication, they have.
The second case to the people who receive oseltamivir in the framework of the so-called "post-exposure prophylaxis" after being exposed to another person with the flu, and those who get sick after that despite receiving the drug.
It is recommended that health professionals, in both cases the response to show a high level of suspicion that resistance to Alooseltamvir may have already emerged. And laboratory investigations must be done in order to identify whether there is a virus-resistant, and whether it should implement infection control measures or strengthened to prevent the spread of the virus.
Also recommended that the Organization should seek, when it is detected by a virus-resistant, to conduct epidemiological investigations to determine whether there is continuity in the transmission. Should also be sought, at the community level, to strengthen surveillance of pandemic strains of H1N1 resistance to Oositamifir.
And called for the need for early treatment with antiviral medicines for those infected with swine flu, and headed "oseltamivir" or "zanamivir" This comes in light of the growing treatment of infections caused by the H1N1 pandemic virus particularly vulnerable patients, more than others, at risk for complications, or who appear their symptoms is high, or in acute signs and symptoms of the disease
http://www.youm7.com/News.asp?NewsID=141773&SecID=97&IssueID=0